Navigation Links
Juventas Therapeutics completes enrollment of Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure
Date:10/28/2013

Ph.D., Chief Medical Officer for Juventas and Director of Research, Summa Cardiovascular Institute at Summa Health Systems. "The goal of STOP-HF is to further define the safety and clinical benefits of JVS-100 in heart failure patients who are already receiving the current standard of care."

Earlier this year, Juventas Therapeutics completed enrollment of STOP-CLI, a Phase IIa first-in-human, double-blinded, placebo-controlled, dose-escalation trial of JVS-100 for patients with Rutherford class 4 or 5 critical limb ischemia (CLI).  The 48-person trial enrolled CLI patients considered poor candidates for revascularization at four centers in the United States and two centers in India.  The primary endpoint for the trial will be safety with efficacy data collected on several key endpoints including amputation rates, Rutherford class, wound closure, and pain management.

"Completing enrollment of STOP-CLI and STOP-HF are significant milestones for the company this year," states Rahul Aras, Ph.D., President and CEO for Juventas Therapeutics.  "To date, more than 120 patients have received JVS-100 therapy and we are building a strong safety profile.  Next year is an important year for Juventas, with efficacy data results targeted from both Phase II studies and additional trials scheduled to enroll.  We are excited to transition JVS-100 into late stage clinical trials and commercialization."

About Juventas Therapeutics

Juventas Therapeutics, headquartered in Cleveland, Ohio, is a privately-held clinical-stage biotechnology company developing therapies for cardiovascular disease. Founded in 2007 with an exclusive license from the Cleveland Clinic, Juventas has transitioned its therapeutic platform from concept to mid-stage clinical trials for treatment of heart failure and critical limb ischemia.  Investors include New Science Ventures, Triathlon Medical Ventu
'/>"/>

SOURCE Juventas Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sorrento Therapeutics Announces Pricing of Public Offering of 4,150,000 Shares of Common Stock and Listing on NASDAQ
2. ISSYS Inc. will showcase its Titan Wireless Implantable Hemodynamic Monitor and its clinical study summary at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference (Booth 1638) in San Francisco (October 29 to 31, 2013)
3. Aratana Therapeutics Adds to Commercial Leadership Team
4. Mirati Therapeutics Prices Public Offering Of Common Stock
5. Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Repros Therapeutics, Inc.
6. Cell Therapeutics to Report Third Quarter Financial Results after Market on October 30, 2013
7. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Osiris Therapeutics, Inc.
8. 3-V Biosciences Presents Positive Data for Novel FASN Inhibitor at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9. Aratana Therapeutics names Wendy Yarno to its Board of Directors
10. PTC Therapeutics to Showcase Breadth of Pipeline at Upcoming R&D Day
11. Cornerstone Therapeutics Inc. Stockholders Seeking More Money Regarding the Proposed Buyout by Chiesi Farmaceutici S.P.A. Encouraged to Contact Lawyers at Deans & Lyons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  The quality function ... description: ensure products meet quality standards at every stage ... escalating regulations, quality leaders also have the challenge of ... Those who don,t effectively balance these priorities ... well as marketplace failure and regulatory scrutiny. ...
(Date:3/27/2015)... -- Dynatronics Corporation (NASDAQ: DYNT ) today announced that ... Company,s Board of Directors effective March 23, 2015, to fill ... board member Joseph Barton .  "The ... Directors represents an important step forward for the company," said ... "Rich is a proven leader and is well-known for his ...
(Date:3/27/2015)... , March 27, 2015 The Temple Health ... April to a 5,000-square-foot building at 1802 South First St. ... area designated by the City of Temple ... & White and the Central Texas Veterans Health Care System, ... laboratory space to early stage biotechnology and life science companies. ...
Breaking Medicine Technology:New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2
... Medical ® today announced that it received Australian Therapeutic ... System for endoscopic lung volume reduction for the treatment ... lung volume reduction system for the treatment of severe ... leaving implants or foreign materials in the lung. ...
... Nev., Dec. 21, 2011   Denali Concrete Management Inc. ... patient enrollment for a phase 3 clinical study of ... in patients with moderate-to-severe Dry Eye Syndrome. This multi-center ... and Israel. The randomized, double-masked clinical trial will include ...
Cached Medicine Technology:Uptake Medical Announces TGA Approval of InterVapor for Patients With Severe Emphysema 2Uptake Medical Announces TGA Approval of InterVapor for Patients With Severe Emphysema 3Denali Concrete Management Inc. Announces the Commencement of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study 2
(Date:3/28/2015)... San Francisco, California (PRWEB) March 28, 2015 ... search for original 1960's Who psychedelic concert posters. The Who ... Flushing, New York on August 2, 1968. According to Hawley, ... 1969 playing many concert halls and college campuses. Perhaps the ... their performance with Jim Morrison and the Doors on August ...
(Date:3/28/2015)... Healthpointe’s otolaryngologists, medical practitioners who attend to ... are now offering a wide variety of treatments for ... by the presence of phantom sounds or ringing in ... a prevalent symptom that can arise due to aging, ... can impede a person’s quality of life. , Dr. ...
(Date:3/28/2015)... ARDX will sponsor the 7th Annual Women’s Wellness Celebration ... Conference Center in Chesapeake, Virginia. Each year, ARDX celebrates ... in the Hampton Roads region. The 2015 Women’s History ... Women grow stronger through sharing their stories and learning the ... WWC™ theme is T-talk where we will share a cup ...
(Date:3/28/2015)... LTW Cyber is an innovation hub for technology ... of addressing the needs of the global market for ... to grow while seeking collaborative opportunities with the other ... in LTW Cyber focus on secure application security, grounded ... and analyzing open source. As the hub matures, ...
(Date:3/27/2015)... In her mid-forties and with a lifelong ... Monica K. arrived at JET Uniform & Supply ... and scared. The owners and staff at JET, which had ... to offer jobs to challenged residents like Monica, were patient. ... to begin with the end in mind,” says Stephen Milaney, ...
Breaking Medicine News(10 mins):Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 2Health News:Canadian Cybersecurity Ventures Globalize as a Collective 3Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3
... (December 20, 2007) One small water line ... bacteria, said international Legionella expert Janet Stout, Ph.D., urging ... against Legionella and other waterborne microbes that contribute to ... known as biofilm, can line every pipe in every ...
... 20 The American Lung,Association of Minnesota and ... seniors to apply for the 2008 Minnesota Clean ... plans to,attend postsecondary education are eligible and encouraged ... biodiesel. Two scholarships will be awarded.,The author of ...
... Offered by One of the Country,s ... Senior Healthcare Experts, RESEDA, ... the world-renowned Los Angeles Jewish Home has,recommended tips for assisting this ... this time of year -- cope with,significant feelings of loss, loneliness ...
... 20 Datascope Corp.,(Nasdaq: DSCP ) today announced ... Annual Meeting will reconvene on Thursday, January 3,2008, at ... LLP, 30,Rockefeller Plaza in New York., Prior to ... all proxy,cards received by Datascope and Ramius Capital were ...
... ANGELES, Dec. 20 By a landslide 87 ... in the Los Angeles,area Wednesday night elected the ... Organizing Committee,(CNA/NNOC), to represent them., The final ... ballot election supervised,by the National Labor Relations Board. ...
... miscarriage boosted the odds by 67%, study found , THURSDAY, ... or an abortion are much more likely than women who ... future, new research shows. , A team at Virginia Commonwealth ... enrolled in the United States Collaborative Perinatal Project. , About ...
Cached Medicine News:Health News:Making hospitals safer from infection 2Health News:It's Not Just About the Children 2Health News:It's Not Just About the Children 3Health News:Datascope Adjourns Annual Meeting of Shareholders to January 3, 2008 2Health News:Whittier Hospital RNs Choose CNA/NNOC in Landslide 87% Election Victory 2Health News:Prior Miscarriage Raises Risk for Low-Birthweight Infant 2
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
Medicine Products: